Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1 8Phase 1/2 3Phase EARLY_PHASE1 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 45Breast 15Thoracic 14Sarcoma 5Other solid neoplasm 5Dermatologic 4Head & Neck 3Gynecologic 3Genitourinary 3Tumor-Agnostic 2CNS 2Plasma cell 1

Conditions

Urinary Bladder Neoplasms 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Melanoma 1Esophageal Neoplasms 1Colorectal Neoplasms 1Castration-resistant Prostate Cancer 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 69Docetaxel 50Nivolumab 44Prednisone 34enzalutamide 30Gemcitabine 26Cyclophosphamide 22Cisplatin 22Paclitaxel 21Radiotherapy 19Carboplatin 19Bevacizumab 19Abiraterone Acetate 18Ipilimumab 17atezolizumab 14Magnetic Resonance Spectroscopy 14fludarabine 13aldesleukin 13Sunitinib 13Interleukin-2 12avelumab 11Radiosurgery 11Pluvicto 11Filgrastim 11Everolimus 11gallium 68 PSMA-11 10fludarabine phosphate 10enfortumab vedotin 10durvalumab 10cemiplimab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Albumin-Bound Paclitaxel × Genitourinary × Clear all
NCT04068896 2025-05-29

Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy

NGM Biopharmaceuticals, Inc

Phase 1/2 Completed
89 enrolled 21 charts
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT00583349 2025-02-17

Intravesicular Abraxane for Treatment-Refractory Bladder Cancer

Columbia University

Phase 1/2 Completed
46 enrolled 11 charts
Genitourinary

Urinary Bladder Neoplasms

NCT04148885 2019-11-04

A Trial of Paclitaxel (Albumin-binding) for Castration-resistant Prostate Cancer

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 1/2 Unknown
44 enrolled
Genitourinary

Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡